Kun-Yu Ke

机构：Fujian Medical University, Mengchao Hepatobiliary Hospital

发表论文 12 篇 · 总被引 34 次 · h-index 3

代表论文

• The impact of metabolic dysfunction–associated fatty liver disease on the prognosis of patients with hepatocellular carcinoma after radical resection (2022 · Hepatobiliary & pancreatic diseases international · 被引 14)
• Impact of MAFLD on the complications after hepatectomy in patients with HBV-related hepatocellular carcinoma (2023 · Medicine · 被引 7)
• Metabolic dysfunction-associated fatty liver disease increases the risk of complications after radical resection in patients with hepatocellular carcinoma (2024 · World Journal of Surgical Oncology · 被引 6)
• Expression and clinical significance of serum lncRNA H19 in patients with metabolic dysfunction-associated fatty liver disease (2025 · Medicine · 被引 2)
• [Validation of the diagnostic value of GALAD model in hepatocellular carcinoma patients]. (2018 · PubMed · 被引 2)
• Serum mir-181a as a potential serological biomarker for metabolic dysfunction-associated fatty liver disease: A cross sectional study (2026 · Medicine · 被引 1)